Morningstar Investor users sign in here.

Stocks

Warren Buffett's Berkshire snaps up insurer for $11.6bn: Morningstar view

Here is how we expect the wide-moat firm to manage the insurer and reinsurer Alleghany Corporation.


Warren Buffett's Berkshire Hathaway has agreed to buy Alleghany shares for $848 a share in cash, or a total equity value of about $11.6 billion. The deal represents a 29% premium to Alleghany's average stock price over the last 30 days, the property/casualty insurer said in a statement. Alleghany Corp. shares soared $167.85, or 25%, following the announement. 

Morningstar view

We expect to increase our fair value estimate for Berkshire Hathaway (BRK.B) by 3%-5% following news. While the deal seems pricey at first glance, with Berkshire offering a 29% premium to Alleghany's average stock price over the last 30 days (and a 16% premium to the firm's 52-week high closing price)--the acquisition price works out to a multiple of 1.26 times Alleghany's book value per share at the end of 2021.

Berkshire has been buying back its own common stock for an average of 1.37 times prior quarter book value per share the past year, so a premium that lifts the deal price for Alleghany up to 1.26 times book seems reasonable to us from a price perspective.

That said, we'll have to see how much value Berkshire can extract from Alleghany's insurance operations, noting that insurance deals can be tricky as the acquirer is assuming potential future claims established by the acquired firm's past underwriting.

While Alleghany's inability to generate excess returns on a consistent basis could be a sign of underwriting weakness, we'd note that the firm's reinsurance arm (which can be hit with large catastrophe losses at any given time) have had a greater influence on overall results the past decade.

We'll also have to see how Berkshire handles the investment portfolio at Alleghany, which has been dedicated more to bonds (80%-85% of holdings the past two years) than equities (15%-20%), the complete opposite of Berkshire's insurance operations (which has had 80%-85% invested in equities).

Should Berkshire avoid unforeseen underwriting issues and reallocate the acquired investment portfolio to more lucrative options, this could end up being a good deal (something Berkshire has struggled to find for much of the past decade).



© 2024 Morningstar, Inc. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. This report has been prepared for clients of Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or New Zealand wholesale clients of Morningstar Research Ltd, subsidiaries of Morningstar, Inc. Any general advice has been provided without reference to your financial objectives, situation or needs. For more information refer to our Financial Services Guide at www.morningstar.com.au/s/fsg.pdf. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Our publications, ratings and products should be viewed as an additional investment resource, not as your sole source of information. Morningstar’s full research reports are the source of any Morningstar Ratings and are available from Morningstar or your adviser. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a financial adviser. Some material is copyright and published under licence from ASX Operations Pty Ltd ACN 004 523 782.

More from Morningstar
3 four-star ASX shares with moats
Stocks
3 four-star ASX shares with moats
These undervalued companies with sustainable competitive advantages may represent attractive opportunities for investors. 
3 best ASX growth stocks to buy for the long term
Stocks
3 best ASX growth stocks to buy for the long term
Three high-quality growth companies that have wide moats and a history of good capital allocation.
Ansell poised to return to growth
Stocks
Ansell poised to return to growth
Progress in productivity program establishes the foundation for earnings growth. 
Our view of CBA earnings
Video
Our view of CBA earnings
Results were strong but are they enough to make the shares attractive? 
ANZ Group and Suncorp: Deal nearly done
Stocks
ANZ Group and Suncorp: Deal nearly done
Our view of the potential acquisition of Suncorp’s banking arm by ANZ.
Cochlear earnings grow rapidly but are the shares a bargain?
Stocks
Cochlear earnings grow rapidly but are the shares a bargain?
Profit is up and the dividend was increased 29% in the latest earnings release.